Home > Drug Search >
  • company_query: Beijing Biostar Technologies
  •   > 
Drug Filter
Category:
chemistry (9) biology (28)
Status:
Approved (2) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (14) Phase Ⅰ (15) IND Filing (1)
Clinical Stage:
Pending (4) Active (26) Discontinued (5)
Bio-Type:
Gene therapy (2) Cell therapy (1) Vaccine (13) Recombinant enzyme (2) Recombinant polypeptide (1) Recombinant cytokines (1) Other recombinant protein (1) Whole antibody (3) Fusion protein (2)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (3) Bladder cancer (3) Breast cancer (1) Chronic lymphocytic leukemia (CLL) (1) Cytomegalovirus infections (1) HIV infection (1) Influenza virus infection (1) Leukemia (1) Melanoma (2) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (1) Myelodysplastic syndrome (MDS) (2) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (4) Non-Hodgkin B-cell lymphomas (1) Obesity (1) Osteoporosis (1) Ovarian cancer (1) Pancreatic cancer (2) Pneumonia (1) Prostate cancer (2) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (2) Solid tumours (3) Thyroid cancer (1) Typhoid (2) Tuberculosis (1) Type 2 diabetes (1) Ulcerative colitis (1) Head and neck cancer (1) Influenza A virus infections (2) Dysentery (1) Anthrax (1) Age-related macular degeneration (AMD) (1) Pain (1) Esophageal adenocarcinoma (1) Staphylococcal infection (1) Glioblastoma (2) Port wine stain (1)
Aprv. Year:
 (1) 2012 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top